| Line item | 2026-01-31 FY | 2025-02-01 FY | 2024-02-03 FY | 2023-01-28 FY | 2022-01-29 FY | 2021-01-30 FY |
|---|---|---|---|---|---|---|
| Revenue | $15.53B | $16.22B | $17.48B | $18.10B | $19.43B | $15.96B |
| Cost of Revenue | $9.23B | $9.66B | $10.50B | $11.46B | $11.44B | $10.36B |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $5.09B | $5.31B | $5.51B | $5.59B | $5.48B | $5.02B |
| Operating Income | $624.00M | $433.00M | $717.00M | $246.00M | $1.68B | -$262.00M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $64.00M | $5.00M | $56.00M | -$39.00M | $281.00M | -$383.00M |
| Net Income | $272.00M | $109.00M | $317.00M | -$19.00M | $938.00M | -$163.00M |
| EPS (basic) | 2.4300 | 0.9800 | 2.8800 | -0.1500 | 6.4100 | -1.0600 |
| EPS (diluted) | 2.3800 | 0.9800 | 2.8500 | -0.1500 | 6.3200 | -1.0600 |
| Shares (diluted) | $114.00M | $112.00M | $111.00M | $120.00M | $148.00 | $154.00M |